Skip to main content

Table 1 Patient baseline characteristics

From: A predictive tool for the assessment of right ventricular dysfunction in non-high-risk patients with acute pulmonary embolism

 

Total

(n = 845)

RV dysfunction

(n = 240)

No RV dysfunction

(n = 605)

p value

Sex (male)

420 (49.7%)

110 (45.8%)

310 (51.2%)

0.16

Age (years)

60.05 ± 15.43

62.50 ± 14.28

59.07 ± 15.76

0.002

Heart rate (beats/min)

86.57 ± 17.81

95.99 ± 20.19

82.84 ± 15.25

 < 0.001

Systolic pressure(mmHg)

124.33 ± 18.26

122.58 ± 21.38

125.03 ± 16.83

0.073

c-Tn I (μg/L)

0.11 ± 0.47

0.19 ± 0.42

0.073 ± 0.48

 < 0.001

NT-pro BNP (pg/mL)

1547.12 ± 3652.06

2858.93 ± 4607.22

1024.73 ± 3046.80

 < 0.001

MPA embolism

209 (24.7%)

119 (49.6%)

90 (14.9%)

 < 0.001

non-MPA embolism

636 (75.3%)

121 (50.4%)

515 (85.1%)

 < 0.001

Saddle-MPA embolism

62 (7.3%)

40 (16.7%)

22 (3.6%)

 < 0.001

RV short-axis diameter (mm)

39.21 ± 7.42

43.97 ± 8.13

37.32 ± 6.40

 < 0.001

LV short-axis diameter (mm)

40.76 ± 7.30

36.42 ± 7.66

42.48 ± 6.40

 < 0.001

RV 4-chamber diameter (mm)

36.38 ± 7.37

40.08 ± 8.10

34.91 ± 6.51

 < 0.001

LV 4-chamber diameter (mm)

39.47 ± 7.36

35.95 ± 7.24

40.87 ± 6.93

 < 0.001

RA 4-chamber diameter (mm)

45.44 ± 9.34

50.12 ± 9.49

43.58 ± 8.61

 < 0.001

LA 4-chamber diameter (mm)

34.83 ± 8.52

32.81 ± 8.40

35.64 ± 8.44

 < 0.001

RV/LV short-axis diameter ratio

1.00 ± 0.30

1.26 ± 0.37

0.89 ± 0.18

 < 0.001

RV/LV 4-chamber diameter ratio

0.96 ± 0.31

1.17 ± 0.42

0.87 ± 0.19

 < 0.001

RA/LA 4-chamber diameter ratio

1.39 ± 0.52

1.65 ± 0.63

1.29 ± 0.40

 < 0.001

  1. c Tn-I, cardiac troponin I; NT-pro BNP, N-terminal pro-brain natriuretic peptide; MPA, main pulmonary artery; RV, right ventricle; LV, left ventricle; RA, right atrium; LA, left atrium